Investor Home

Financial

Press Releases

Kimberly-Clark Holds Annual Meeting

Kimberly-Clark Holds Annual Meeting DALLAS, April 24, 2003—At Kimberly-Clark Corporation's (NYSE: KMB) annual meeting today, shareholders re-elected four directors to three-year terms expiring in 2006.

Directors who were re-elected are Thomas J. Falk, chairman and chief executive officer of Kimberly-Clark; Dennis R. Beresford, Ernst & Young executive professor of accounting, University of Georgia; Mae C. Jemison, M.D., president, The Jemison Group, Inc.; and Randall L. Tobias, chairman emeritus, Eli Lilly and Company.

The Kimberly-Clark board is comprised of 11 members divided into three classes. There are four members in the class of 2006, three members in the class of 2005 and four members in the class of 2004.

Shareholders also approved the selection of Deloitte & Touche LLP as independent auditors.

In other matters, shareholders voted on four shareholder proposals. A majority of shareholders voted in favor of proposals recommending that stock options be expensed and that the board redeem the company's existing shareholder rights plan and not adopt any future plan without shareholder approval. In addition, a majority of shareholders supported the board's recommendation by voting against proposals for indexing stock options for executives and establishing an independent chairman of the board.

In commenting on the outlook for 2003, Chairman and CEO Falk said that Kimberly-Clark remains focused on driving sales volumes higher by 3 to 5 percent and reducing costs by $175 million to $200 million in 2003.

To increase sales volumes, Falk said the company will build on its strong global brand positions through new product innovations and high-margin line extensions. On the cost-savings front, he added that K-C will reduce raw material expenses and manufacturing waste worldwide and increase productivity and distribution efficiencies.

"Our worldwide team of 64,000 K-Cers is energized and pushing hard to achieve these objectives," Falk said. "We know what Kimberly-Clark must do in 2003. We will get it done. And in the end, we'll be a stronger, more profitable company."

Replay of Business Review from 2003 Annual Meeting

Stockholders and others are invited to listen to an audio playback and PowerPoint presentation of the business review portion of the 2003 annual meeting. This replay can be accessed shortly after the meeting by following instructions set out in the Investors section of the company's Web site at www.kimberly-clark.com.

About Kimberly-Clark

Kimberly-Clark is a leading manufacturer and marketer of global consumer brands with annual sales of $13.6 billion. It is home to some of the world's most recognized and trusted brands, including Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend. Other well-known Kimberly-Clark brands outside North America include Andrex, Scottex, Page, Popee and Kimbies. The company's tissue, personal care and health care products are manufactured in 43 countries and sold in more than 150. Nearly one-quarter of the world's population, or 1.3 billion people, use Kimberly-Clark products each year. For more information about Kimberly-Clark, visit the Kimberly-Clark Web site at www.kimberly-clark.com.

Certain matters contained in this news release concerning the business outlook, including new product introductions, cost savings and acquisitions, anticipated financial and operating results, strategies, contingencies and transactions of the company constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company. There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated. For a description of certain factors that could cause the company's future results to differ materially from those expressed in any such forward-looking statements, see the section of Part I, Item 1 of the company's Annual Report on Form 10-K for the year ended December 31, 2002 entitled "Factors That May Affect Future Results."